Evogene Ltd. (EVGN)
NASDAQ: EVGN
· Real-Time Price · USD
1.33
-0.03 (-2.21%)
At close: Aug 15, 2025, 1:17 PM
Evogene Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.44M | 1.61M | 1.8M | 914K | 4.19M | 578K | 3.77M | 654K | 641K | 660K | 466K | 312K | 237K | 311K | 151K | 135K | 333K |
Cost of Revenue | 1.61M | 755K | 1.08M | 1.15M | 310K | 1.06M | 511K | 461K | 322K | 364K | 120K | 262K | 163K | 267K | 101K | 128K | 271K |
Gross Profit | 830K | 856K | 715K | -236K | 3.88M | -483K | 3.26M | 193K | 319K | 296K | 346K | 50K | 74K | 44K | 50K | 7K | 62K |
Operating Income | -4.13M | -4.57M | -7.46M | -6.1M | -4.09M | -7.63M | -4.18M | -7.9M | -6.8M | -3.78M | -7.1M | -8.01M | -8.05M | -8.69M | -8.56M | -7.45M | -6.26M |
Interest Income | 1.6M | n/a | 2.15M | 260K | 407K | 120K | 429K | 391K | 308K | 169K | 194K | 444K | 41K | 938K | 380K | 565K | 52K |
Pretax Income | -2.99M | 2K | -8.22M | -5.96M | -3.85M | -7.34M | -3.86M | -7.76M | -7.03M | -3.78M | -7.16M | -9.72M | -9.1M | -8.09M | -8.34M | -6.89M | -7.11M |
Net Income | -2.59M | 427K | -7.63M | -5.42M | -3.86M | -6.6M | -3.98M | -7.02M | -6.27M | -3M | -6.54M | -8.82M | -8.28M | -7.37M | -7.61M | -6.21M | -6.6M |
Selling & General & Admin | 1.94M | 2.02M | 3.74M | 2.46M | 2.65M | 2.26M | 2.38M | 2.73M | 2.31M | 2.83M | 1.55M | 1.68M | 1.59M | 2M | 2M | 1.79M | 1.45M |
Research & Development | 3.21M | 3.4M | 4.43M | 3.4M | 4.8M | 4.88M | 5.06M | 5.37M | 4.8M | 4.75M | 5.89M | 6.38M | 6.53M | 6.74M | 6.6M | 5.66M | 4.87M |
Other Expenses | -191K | n/a | n/a | 5K | n/a | n/a | n/a | n/a | n/a | -3.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.96M | 5.42M | 8.17M | 5.86M | 7.97M | 7.14M | 7.44M | 8.09M | 7.12M | 4.08M | 7.44M | 8.06M | 8.13M | 8.74M | 8.61M | 7.45M | 6.32M |
Interest Expense | 464K | 144K | 2.91M | 122K | 166K | -383K | 109K | 247K | 538K | 163K | 255K | 2.15M | 1.09M | 336K | 159K | 14K | 905K |
Selling & Marketing Expenses | 645K | -1.95M | 855K | 928K | 992K | -1.57M | 850K | 928K | 800K | 1.17M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 6.57M | 6.18M | 9.25M | 7.02M | 8.28M | 8.21M | 7.95M | 8.55M | 7.44M | 4.44M | 7.56M | 8.32M | 8.29M | 9M | 8.71M | 7.58M | 6.59M |
Income Tax Expense | n/a | 7K | 1K | 1K | n/a | -4K | -5K | 21K | -45K | 45K | 5K | 38K | 2K | -6K | 8K | 3K | 8K |
Shares Outstanding (Basic) | 6.8M | 6.8M | 5.81M | 5.09M | 5.06M | 5.06M | 4.89M | 4.52M | 4.15M | 41.23M | 41.22M | 41.2M | 41.19M | 41.18M | 40.85M | 40.58M | 38.96M |
Shares Outstanding (Diluted) | 6.8M | 6.8M | 5.81M | 5.09M | 5.06M | 5.06M | 4.89M | 4.52M | 4.15M | 41.23M | 41.22M | 41.2M | 41.19M | 41.18M | 40.85M | 40.58M | 38.96M |
EPS (Basic) | -0.38 | 0.06 | -1.31 | -1.06 | -0.76 | -1.3 | -0.81 | -1.55 | -1.51 | -0.07 | -0.16 | -0.24 | -0.22 | -0.18 | -0.19 | -0.15 | -0.17 |
EPS (Diluted) | -0.38 | 0.06 | -1.31 | -1.06 | -0.76 | -1.3 | -0.81 | -1.55 | -1.51 | -0.07 | -0.16 | -0.24 | -0.22 | -0.18 | -0.19 | -0.15 | -0.17 |
EBITDA | -1.95M | -2.54M | -4.68M | -5.23M | -3.01M | -6.96M | -3.09M | -6.86M | -5.85M | -2.97M | -6.26M | -6.95M | -7.33M | -8.3M | -7.63M | -6.31M | -5.65M |
EBIT | -2.52M | -3.13M | -5.31M | -5.86M | -3.68M | -8.12M | -3.75M | -7.51M | -6.49M | -3.61M | -6.9M | -7.56M | -8.01M | -8.85M | -8.18M | -6.88M | -6.21M |
Depreciation & Amortization | 579K | 593K | 627K | 613K | 671K | 663K | 661K | 647K | 641K | 641K | 645K | 613K | 681K | 552K | 548K | 574K | 560K |